IBD Registry in a Sub-Saharan African Population

Last updated: July 9, 2024
Sponsor: University of Zimbabwe
Overall Status: Active - Recruiting

Phase

N/A

Condition

Colic

Bowel Dysfunction

Inflammatory Bowel Disease

Treatment

No intervention

Clinical Study ID

NCT04178408
IBDZIM
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The investigators intend to establish a prospective registry of patients diagnosed with inflammatory bowel disease at Parirenyatwa hospital in Harare, Zimbabwe. The study will periodically collect data on disease phenotype, disease course, and clinical management, and will biobank stool specimens and germline DNA. One relative, and an individual from the same neighbourhood will be also be recruited for a nested case-control study into risk factors of inflammatory bowel disease in this population.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Cases
  1. Any patient with confirmed inflammatory bowel disease

  2. Onset of disease ≥3 months ago.

  • Controls
  1. Age ≥ 18 years (NB - cases younger than 18 will be excluded from case-controlanalysis

  2. One sibling or cousin (2nd degree) and one neighbourhood control.

Exclusion

Exclusion Criteria:

  • Cases
  1. None
  • Controls
  1. Suspected inflammatory bowel disease

  2. Unexplained gastrointestinal symptoms including diarrhoea, vomiting, chronicabdominal pain, weight loss, rectal bleeding, and recent change in bowel habit.

  3. Previous unexplained gastrointestinal surgery

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: No intervention
Phase:
Study Start date:
January 02, 2021
Estimated Completion Date:
December 31, 2025

Study Description

A prospective observational registry with a nested case-control study will be established at a gastrointestinal outpatient's clinic at a tertiary care hospital in Harare, Zimbabwe. The registry will recruit confirmed cases of inflammatory bowel disease from the clinic, other hospitals within and outside Harare, and from private practitioners. Two controls, a sibling or cousin, and an individual living in the same neighbourhood will also be recruited for each case. Demographic and clinical data will be obtained for all cases at baseline, after 6 months and annually thereafter. A questionnaire adapted from the International Organisation of IBD for risk factors of inflammatory bowel disease, and a food frequency questionnaire will be administered to all participants. Stool specimens, and germline DNA from peripheral blood will be biobanked in the Department of Medicine at the University of Zimbabwe. Preliminary data analysis will be carried out after at least 100 patients have been recruited. Descriptive statistics will be used to summarise data on demographic and phenotypic characteristics of inflammatory bowel disease, and incidence will be estimated for Harare. Risk factors for inflammatory bowel disease will be analysed using conditional logistic regression.

Connect with a study center

  • Parirenyatwa Hospital

    Harare,
    Zimbabwe

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.